Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,327 total articles
Chidozie Ugwumba, a significant stakeholder holding a 10% ownership position in Clene Inc. (NASDAQ: CLNN), has completed a series of common stock sales. These transactions, which took place over a three-day window in late April 2026, resulted in total proceeds of $112,778. The divestments were carried out indirectly via SymBiosis II, LLC.
A recent regulatory filing has revealed that Erika R. Caesar, the Executive Vice President and General Counsel of Bancorp, Inc. (NASDAQ:TBBK), has completed a sale of her company stock. The transaction, which took place on April 29, 2026, involved the disposal of 4,470 shares of Bancorp common stock. The total value of this divestment is estimated …
Maria Wainwright, who serves as the Executive Vice President and Chief Marketing Officer at Bancorp, Inc. (NASDAQ: TBBK), has completed a sale of company common stock. The transaction, occurring on April 28, 2026, involved 8,400 shares and resulted in total proceeds of $506,020. This move follows a first-quarter earnings report that presented a div…
Matthew Neagle, the Chief Operating Officer of Porch Group, Inc. (NASDAQ: PRCH), has completed a sale of company common stock totaling $485,821. The transaction involved 59,901 shares and took place on April 28, 2026, according to recent SEC filings. This movement comes at a time when Porch Group is navigating various financial metrics, including r…
Shawn Tabak, the Chief Financial Officer of Porch Group, Inc. (NASDAQ:PRCH), completed a sale of 10,454 shares of common stock on April 28, 2026. The transaction, valued at a total of $84,786, occurred at prices between $7.69 and $8.45 per share, resulting in a weighted average price of $8.1104. This move was not a discretionary market sale but rat…
Matt Ehrlichman, who serves as the Founder, Chairman, and CEO of Porch Group, Inc. (NASDAQ:PRCH), has completed a series of stock sales totaling approximately $937,902. The transactions involved the sale of 115,642 shares of the company's common stock on April 28, 2026. These sales were conducted through multiple transactions at various price point…
Christine Ring, the Chief Legal Officer at Nurix Therapeutics, Inc. (NASDAQ: NRIX), recently engaged in transactions involving company common stock. Following the vesting of restricted stock units, Ms. Ring acquired 8,608 shares and subsequently sold 3,214 shares to satisfy tax withholding requirements. This activity occurred against a backdrop of …
Hans van Houte, the Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), completed several equity transactions on April 30, 2026. The activity involved both the acquisition of new shares through the vesting of restricted stock units (RSUs) and a sale of existing shares to address tax-related requirements. While the sale represents a r…
Gwenn Hansen, the Chief Scientific Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX), conducted a series of transactions involving company common stock on April 30, 2026. These actions included the sale of 3,214 shares to meet tax withholding requirements and the acquisition of 8,608 shares through the vesting of restricted stock units (RSUs). Foll…
Anika Therapeutics, Inc. (NASDAQ: ANIK) President and CEO Stephen D. Griffin has increased his direct ownership in the company through a recent open-market transaction. The acquisition occurred on April 30, 2026, totaling $149,880 for 12,200 shares of common stock. This move follows a period of downward pressure on the company's share price, which …
Forager Fund, L.P., a significant stakeholder holding a ten percent interest in Regional Management Corp. (RM), has completed a series of stock sales totaling approximately $195,444. The divestment took place over a two-day period in late April 2026, involving the disposal of 5,017 shares of common stock at various price points.
Jason P. Rhodes, a director at Dyne Therapeutics, Inc. (NASDAQ: DYN), has completed a significant sale of common stock totaling approximately $4,178,516. The transaction involved 227,337 shares sold on April 28, 2026, within a price range of $18.00 to $19.00 per share. This divestment occurred through a pre-established Rule 10b5-1 trading plan adop…
Shantanu Narayen, the Chair and Chief Executive Officer of Adobe Inc., has completed a significant sale of company stock totaling more than $18 million. According to recent SEC Form 4 filings, the transactions involved 75,000 shares of Adobe common stock (NASDAQ: ADBE) on April 28, 2026. These sales were conducted indirectly through The Narayen Fam…
Jeffrey J. Brown, a member of the board of directors at Upbound Group, Inc. (NYSE:UPBD), has increased his position in the company through multiple transaction types totaling over $45,000 in common stock. These acquisitions occurred on April 28, 2026, and coincide with a period of varied financial performance for the firm, which recently reported e…
George Djurasovic, serving as the Interim General Counsel for Principal Financial Group Inc. (NASDAQ: PFG), has completed two transactions involving the sale of company common stock. The total value of these disposals reached approximately $259,332 during late April 2026. These sales occur against a backdrop of recent positive financial reporting a…
Richard N. Nottenburg, a member of the Board of Directors at Applied Digital Corp. (NASDAQ: APLD), has completed the sale of 25,000 shares of common stock. The transactions, which represent a total value of $832,375, were disclosed in a recent Form 4 filing with the Securities and Exchange Commission. The sales took place over two days at the end o…
Joey B. Hogan, a director for Covenant Logistics Group, Inc. (NASDAQ:CVLG), recently completed a sale of company stock totaling roughly $510,927. The transaction, which took place on April 28, 2026, involved the disposal of 14,700 shares of Class A Common Stock. This movement comes at a time when the company's stock is trading near its 52-week peak…
Peter Rahmer, the Chief Corporate Development Officer at Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction occurred on April 28, 2026, involving the disposal of 753 shares at a price point of $14.79 per share. This movement resulted in total proceeds of $11,136.The sale was not a discretionary ma…
George K. Ng, serving as both the Chief Executive Officer and a Director of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), has completed a purchase of common stock in the company. The transaction, which took place on March 31, 2026, involved the acquisition of 2,136 shares at a price point of $2.535 per share, representing a total investment value …
David L. Finkelstein, serving as CEO and Co-CIO of Annaly Capital Management Inc., has completed a sale of 50,000 shares of common stock. The transaction, valued at approximately $1,144,000, occurred on April 27, 2026. This divestment was executed through a Rule 10b5-1 trading plan established on May 16, 2024, specifically intended for estate and t…
Caroline Alting, who serves as the Senior Vice President of Operations Excellence & Sustainability at Noble Corp plc (NYSE: NE), has completed a sale of her company stock. The transaction involved 15,340 A Ordinary Shares, executed on April 28, 2026. This move comes during a period of significant price appreciation for Noble Corp, as the stock rece…
Owlet, Inc. (NASDAQ: OWLT) Chief Financial Officer Amanda Crawford has reported a series of stock sales totaling $112,794. The transactions, which involved the sale of 11,705 shares, occurred at varying price points ranging from $3.20 to $11.50 per share. These disposals were non-discretionary in nature, executed through automatic processes designe…
Martin Roper, the Chief Executive Officer of Vita Coco Company, Inc. (NASDAQ:COCO), has completed a series of stock transactions totaling approximately $2.5 million. The sales occurred over a two-day period in late April 2026, involving 45,544 shares of common stock. These disposals took place against a backdrop of intense upward momentum for the c…
Exzeo Group, Inc. (NASDAQ: XZO) has seen notable insider activity following a recent filing with the Securities and Exchange Commission. Chief Executive Officer Paresh Patel executed a direct purchase of common stock, adding to his existing holdings. This transaction occurs against a backdrop of recent share price volatility, as the company's stock…
Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction, valued at $14,375, occurred on April 28, 2026. The shares were sold at a price point of $14.79 per share, which represents a premium compared to the current trading level of $12.96.The sale involve…
